Impact of the donor risk index in the outcome of HCV plus liver transplant recipients.

被引:0
|
作者
Maluf, Daniel G. [1 ]
Edwards, Erick B. [2 ]
Stravitz, Todd R. [1 ]
Kauffman, Myron H. [2 ]
机构
[1] Virginia Commonwealth Univ, Hume Lee Transplant Ctr, Richmond, VA USA
[2] United Network Organ Sharing, Richmond, VA USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:304 / 305
页数:2
相关论文
共 50 条
  • [11] Weaning of Immunosuppression in Living Donor Liver Transplant Recipients.
    Takatsuki, Mitsuhisa
    Soyama, Akihiko
    Torashima, Yasuhiro
    Ohno, Shinichiro
    Kinoshita, Ayaka
    Natsuda, Koji
    Fujii, Mio
    Adachi, Tomohiko
    Kitasato, Amane
    Kuroki, Tamotsu
    Eguchi, Susumu
    LIVER TRANSPLANTATION, 2013, 19 : S90 - S90
  • [12] Donor age influences survival of liver transplant recipients.
    Orrego, M
    Vargas, HE
    Guo, LS
    Balan, V
    De Petris, G
    Douglas, DD
    Byrne, T
    Moss, A
    Reddy, KS
    Mulligan, D
    Rakela, J
    LIVER TRANSPLANTATION, 2005, 11 (07) : C12 - C12
  • [13] Higher resource utilization in adult living donor liver transplant recipients compared to deceased donor liver transplant recipients.
    Conway, JD
    Russo, MW
    Johnson, M
    Shrestha, R
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 294 - 294
  • [14] Pharmacokinetics of tacrolimus in live donor and deceased donor liver transplant recipients.
    Jain, Ashok
    Venkatramanan, Raman
    Kwong, Tai
    Orloff, Mark
    Abt, Peter
    Kashyap, Randeep
    Tsoulfas, Geogious
    Mack, Cindy
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 547 - 547
  • [15] Outcome of Partial Splenic Embolization in Liver Transplant Recipients.
    Begum, Rehana
    Paz-Fumagalli, Ricardo
    Walser, Eric M.
    Bathala, Venugopal
    Taner, Burcin
    Keaveny, Andrew P.
    Dickson, Rolland
    Nguyen, Justin H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 523 - 523
  • [16] Renal function after living donor liver transplant - Comparison with deceased donor liver transplant recipients.
    Pal, AK
    Douglas, DD
    Reddy, KS
    Heilman, RL
    Moss, AA
    Mulligan, DC
    Mazur, MJ
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 209 - 209
  • [17] Sirolismus in post hepatitis C virus (HCV) liver transplant recipients.
    Marrero, R
    Neff, GW
    Montalbano, M
    Nery, J
    Weppler, D
    Schiff, ER
    Tzakis, AG
    HEPATOLOGY, 2002, 36 (04) : 664A - 664A
  • [18] Use of HCV Ab plus /NAT- Donors in HCV Naive Renal Transplant Recipients.
    Dao, A.
    Cuffy, M.
    Kaiser, T.
    Loethen, A.
    Cafardi, J.
    Shields, A.
    Cardi, M.
    Alloway, R.
    Govil, A.
    Sherman, K.
    Shah, S.
    Woodle, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 287 - 287
  • [19] Evidence for reduced HCV clearance rates in immunosuppresssed liver transplant recipients.
    Chang, M
    Mittler, J
    Williams, O
    Fasch, W
    Forquera, A
    Carithers, RL
    Gretch, DR
    HEPATOLOGY, 2002, 36 (04) : 270A - 270A
  • [20] TEMPORAL AND REGIONAL TRENDS IN DONOR SELECTION FOR HEPATITIS C VIRUS (HCV)-INFECTED LIVER TRANSPLANT (LT) RECIPIENTS USING THE HCV DONOR RISK INDEX (HCV-DRI)
    Terrault, Norah
    Biggins, Scott
    Dodge, Jennifer L.
    Feng, Sandy
    HEPATOLOGY, 2010, 52 (04) : 323A - 324A